Polartec LLC to License Stay-Fresh(R) Antimicrobial Technology
27 August 2013 - 2:01PM
Marketwired
GAINESVILLE, FL--(Marketwired -
August 27, 2013) - Quick-Med Technologies, Inc.
(OTCQB: QMDT), a life sciences company that is developing
innovative technologies for the healthcare and consumer markets,
announced today that it has signed a license for a range of
products and fields of use with Polartec LLC, a premium producer of
textile solutions.
"We are very pleased to enter into this partnership with such a
strongly positioned and technologically advanced partner as
Polartec, whose leadership and innovation in performance textiles
is recognized worldwide. Our Stay Fresh technology can permit
Polartec to unlock added value in their product offerings, as well
as access entire new segments with their performance fabrics, and
strong network of industrial partners," said Bernd Liesenfeld,
Quick-Med's President.
About Stay
Fresh
Stay Fresh is Quick-Med's
newest technology platform. This technology is based on
hydrogen peroxide -- a well known consumer antimicrobial product
that is commonly used in households for disinfecting cuts, scrapes,
toothbrushes and more. Hydrogen peroxide is also produced by
human cells to combat invasive bacteria, and is a naturally
occurring preservative component of milk and honey. EPA has
registered Stay Fresh to be
utilized to protect a broad selection of treated goods for consumer
use, including textiles, decorative fabrics, and functional fabrics
such as filters and carpets. FDA has also granted clearance to
market an antibacterial medical textile based on Stay Fresh Technology. The
Stay Fresh technology
offerings provided by Quick-Med are expanding continuously, with
development of additional applications including antimicrobial
surface treatments, and superabsorbent antimicrobial powders to
complement the range of products that are already cleared for
consumer use under EPA or FDA jurisdiction.
About Quick-Med Technologies,
Inc.
Quick-Med Technologies, Inc. is a life sciences company that is
developing and commercializing proprietary, broad-based
technologies for the consumer and healthcare markets. The
Company's NIMBUS®
technology is the first FDA-cleared, non-leaching antimicrobial
technology available in a wound dressing. Its Stay Fresh® technology provides highly
durable antimicrobial protection for apparel and other textile
applications, with consumer applications of Stay Fresh Technology having EPA
registration for the treated articles, as well as an FDA clearance
for an antibacterial medical textile product. Quick-Med
develops antimicrobial technologies to promote public health,
safety and comfort. For more information, see:
www.quickmedtech.com.
About Polartec, LLC
Polartec, LLC is the premium producer of innovative textile
solutions. Since inventing modern synthetic fleece in 1981, the
engineers at Polartec have continued to push the limits of fabric
technology. Today, Polartec supplies the world with the most
advanced fabric innovations. Polartec products range from advanced
lightweight wicking fabric, to insulation and weather protection
textiles and are utilized by leading apparel brands, the U.S.
military and other global militaries, flame resistance, work wear,
and contract upholstery markets. For more information,
visit polartec.com.
© 2013 Quick-Med Technologies, Inc. All rights
reserved. NIMBUS®, and
Stay Fresh® are registered trademarks of
Quick-Med Technologies, Inc.
Forward-looking statements
(statements which are not historical facts) in this release are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. For this purpose, any
statements contained in this release that are not statements of
historical fact may be deemed to be forward-looking statements.
Without limiting the generality of the foregoing, words such as
"may", "will", "to", "expect", "plan", "believe", "anticipate",
"intend", "could", "would", "estimate", and/or "continue" or the
negative or other variations thereof or comparable terminology are
intended to identify forward-looking statements involve risks and
uncertainties, including those risks that are discussed in the
Company's filings with the Securities and Exchange Commission
("SEC"), which may be accessed at the SEC's Edgar System at
www.sec.gov.
CONTACT: Quick-Med Technologies Bernd Liesenfeld,
President (352) 379-0611 bliesenfeld@quickmedtech.com
Quick Med Technologies (CE) (USOTC:QMDT)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Quick Med Technologies (CE) (USOTC:QMDT)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
